Takeda Pharmaceutical Operating Margin 2007-2018 | TAK

Current and historical operating margin for Takeda Pharmaceutical (TAK) over the last 10 years. The current operating profit margin for Takeda Pharmaceutical as of December 31, 2018 is 21.32%.
Takeda Pharmaceutical Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2018-12-31 $16.65B $5.09B 30.55%
2018-06-30 $15.87B $4.49B 28.31%
2017-06-30 $15.40B $7.26B 47.11%
2016-06-30 $15.52B $-5.42B -34.91%
2015-06-30 $15.56B $-2.76B -17.76%
2015-03-31 $15.92B $-2.56B -16.07%
2014-12-31 $16.23B $-2.25B -13.86%
2014-09-30 $16.60B $13.20B 79.49%
2014-06-30 $16.75B $13.34B 79.67%
2014-03-31 $16.90B $13.24B 78.34%
2013-12-31 $16.64B $12.98B 78.00%
2013-09-30 $17.07B $13.41B 78.55%
2013-06-30 $17.79B $14.13B 79.41%
2013-03-31 $18.71B $14.51B 77.56%
2012-12-31 $19.80B $15.60B 78.80%
2012-09-30 $20.33B $16.13B 79.35%
2012-06-30 $19.84B $15.65B 78.85%
2012-03-31 $18.87B $18.87B 100.00%
2011-12-31 $17.78B $17.78B 100.00%
2011-09-30 $12.30B $12.30B 100.00%
2011-03-31 $11.44B $11.44B 100.00%
2010-03-31 $10.16B $10.16B 100.00%
2009-09-30 $8.96B $8.96B 100.00%
2009-03-31 $11.33B $11.33B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $27.482B $18.875B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.500B 34.82
Grifols (GRFS) Spain $13.834B 17.50
Sage Therapeutics (SAGE) United States $9.115B 0.00
Ionis Pharmaceuticals (IONS) United States $9.045B 19.77
Catalent (CTLT) United States $7.746B 31.09
Jazz Pharmaceuticals (JAZZ) Ireland $7.731B 10.60
Neurocrine Biosciences (NBIX) United States $7.379B 0.00
Nektar Therapeutics (NKTR) United States $6.035B 9.84
Tilray (TLRY) Canada $4.551B 0.00
FibroGen (FGEN) United States $3.642B 0.00
United Therapeutics (UTHR) United States $3.385B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.358B 11.78
Arrowhead Pharmaceuticals (ARWR) United States $2.609B 393.14
PTC Therapeutics (PTCT) United States $2.455B 0.00
Xencor (XNCR) United States $2.173B 59.32
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.968B 7.09
USANA Health Sciences (USNA) United States $1.816B 15.78
Pacira Pharmaceuticals (PCRX) United States $1.799B 87.12
Portola Pharmaceuticals (PTLA) United States $1.755B 0.00
Tricida (TCDA) United States $1.727B 0.00
Zogenix (ZGNX) United States $1.677B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.615B 22.07
Ironwood Pharmaceuticals (IRWD) United States $1.607B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.520B 0.00
Heron Therapeutics (HRTX) United States $1.436B 0.00
Aerie Pharmaceuticals (AERI) United States $1.356B 0.00
Turning Point Therapeutics (TPTX) United States $1.323B 0.00
Esperion Therapeutics (ESPR) United States $1.319B 0.00
Corcept Therapeutics (CORT) United States $1.186B 16.93
ArQule (ARQL) United States $1.186B 0.00
Radius Health (RDUS) United States $1.068B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.943B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.899B 0.00
Endo (ENDP) Ireland $0.837B 1.35
Aptorum Group (APM) China $0.761B 0.00
Odonate Therapeutics (ODT) United States $0.752B 0.00
CannTrust Holdings (CTST) Canada $0.686B 0.00
Organogenesis Holdings (ORGO) United States $0.670B 0.00
Translate Bio (TBIO) United States $0.633B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.595B 0.00
TherapeuticsMD (TXMD) United States $0.593B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.567B 0.00
Akebia Therapeutics (AKBA) United States $0.522B 0.00
Dermira (DERM) United States $0.516B 0.00
ChemoCentryx (CCXI) United States $0.506B 0.00
GlycoMimetics (GLYC) United States $0.492B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Siga Technologies (SIGA) United States $0.440B 1.04
Flexion Therapeutics (FLXN) United States $0.429B 0.00
Collegium Pharmaceutical (COLL) United States $0.421B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.421B 21.25
BioCryst Pharmaceuticals (BCRX) United States $0.399B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.373B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.371B 0.00
Rafael Holdings (RFL) United States $0.370B 0.00
Karyopharm Therapeutics (KPTI) United States $0.358B 0.00
KalVista Pharmaceuticals (KALV) United States $0.355B 0.00
TCR2 Therapeutics (TCRR) United States $0.351B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.348B 0.00
Forty Seven (FTSV) United States $0.339B 0.00
Harpoon Therapeutics (HARP) United States $0.303B 0.00
OptiNose (OPTN) United States $0.294B 0.00
Xeris Pharmaceuticals (XERS) United States $0.291B 0.00
Dova Pharmaceuticals (DOVA) United States $0.289B 0.00
Molecular Templates (MTEM) United States $0.289B 0.00
CASI Pharmaceuticals (CASI) United States $0.286B 0.00
Concert Pharmaceuticals (CNCE) United States $0.275B 0.00
ImmunoGen (IMGN) United States $0.272B 0.00
Aratana Therapeutics (PETX) United States $0.256B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.244B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.230B 0.00
Lannett Co Inc (LCI) United States $0.223B 2.17
Recro Pharma (REPH) United States $0.219B 0.00
Minerva Neurosciences (NERV) United States $0.217B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.205B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.193B 0.00
Bio Blast Pharma (ENLV) Israel $0.187B 0.00
MEI Pharma (MEIP) United States $0.185B 0.00
Aclaris Therapeutics (ACRS) United States $0.182B 0.00
Ocular Therapeutix (OCUL) United States $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.179B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.172B 0.00
Aldeyra Therapeutics (ALDX) United States $0.171B 0.00
Nature's Sunshine Products (NATR) United States $0.164B 53.06
Ardelyx (ARDX) United States $0.157B 0.00
Calithera Biosciences (CALA) United States $0.147B 0.00
AgeX Therapeutics (AGE) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.146B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.141B 0.00
Redhill Biopharma (RDHL) Israel $0.140B 0.00
IMV INC (IMV) Canada $0.139B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.138B 0.00
Majesco Entertainment (PTE) United States $0.136B 0.00
Neon Therapeutics (NTGN) United States $0.131B 0.00
Tyme Technologies (TYME) United States $0.115B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.115B 0.00
DURECT (DRRX) United States $0.106B 0.00
Aquestive Therapeutics (AQST) United States $0.105B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.102B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 70.56
Avenue Therapeutics (ATXI) United States $0.099B 0.00
Infinity Pharmaceuticals (INFI) United States $0.096B 0.00
Cardiome Pharma (CORV) Canada $0.095B 0.00
Champions Oncology (CSBR) United States $0.094B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.093B 0.00
China SXT Pharmaceuticals (SXTC) China $0.092B 0.00
Mast Therapeutics (SVRA) United States $0.087B 0.00
Natural Alternatives (NAII) United States $0.087B 8.72
MediWound (MDWD) Israel $0.087B 0.00
Iterum Therapeutics (ITRM) Ireland $0.085B 0.00
Nivalis Therapeutics (ALPN) United States $0.084B 0.00
Capnia (SLNO) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Adherex Technologies (FENC) United States $0.077B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
Melinta Therapeutics (MLNT) United States $0.070B 0.00
Novan (NOVN) United States $0.070B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
Neos Therapeutics (NEOS) United States $0.061B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.060B 0.00
CTI BioPharma (CTIC) United States $0.054B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
ElectroCore (ECOR) United States $0.051B 0.00
Genocea Biosciences (GNCA) United States $0.049B 0.00
Forward Pharma (FWP) Denmark $0.049B 0.00
Zafgen (ZFGN) United States $0.048B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.045B 0.00
KemPharm (KMPH) United States $0.044B 0.00
ProNAi Therapeutics (SRRA) Canada $0.043B 0.00
Opexa Therapeutics (ACER) United States $0.042B 0.00
BioLineRx (BLRX) Israel $0.041B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
ContraFect (CFRX) United States $0.040B 0.00
Bio-Path Holdings (BPTH) United States $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
PharmAthene (ALT) United States $0.029B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.029B 0.00
ProPhase Labs (PRPH) United States $0.029B 0.00
IsoRay (ISR) United States $0.028B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Heat Biologics (HTBX) United States $0.024B 0.00
GTx (ONCT) United States $0.024B 0.00
Pain Therapeutics (SAVA) United States $0.022B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.61
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
Shineco (TYHT) China $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Achieve Life Sciences (ACHV) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.013B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.80
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.010B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00